Detalles de la búsqueda
1.
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
JAMA;
325(1): 50-58, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300950
2.
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Breast Cancer (Dove Med Press);
16: 223-231, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628818
3.
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).
Clin Cancer Res;
28(4): 637-645, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34810217
Resultados
1 -
3
de 3
1
Próxima >
>>